Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort studyJun‐Te Hsu, Ta‐Sen Yeh, Chia‐Jung Kuo et al.|Oncotarget|2017Cited by 10
Survival impact of the number of lymph node retrieved on patients with node-negative gastric cancer: more is better?Jun‐Te Hsu, Yi-Yin Jan, Puo‐Hsien Le et al.|Translational Gastroenterology and Hepatology|2017Cited by 5